VAZQUEZ CHRIS (Chief Accounting Officer) sold 11.7% of their position (211.00 shares) of BIODESIX INC on the open market
Open‑market sale worth $2.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/23/2026ACC: 0000905148-26-000990
Officer· Chief Accounting Officer
Since Feb 2026
-211.00
Net shares
Net seller
$2.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
563.00 acquired · 774.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+563.00
Price / share
—
Trade value
—
% of position
45.6%
2/20/2026
1.23K→1.80K
Common Stock
Direct
Shares
−211.00
Price / share
$12.78
Trade value
$2.70K
% of position
11.7%
2/23/2026
1.80K→1.59K
Total
Net shares
+352.00
Net value
-$2.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2026 | M · Option Exercise | +563.00 | — | — | 45.6% | 1.23K | 1.80K |
| Common Stock Direct | 2/23/2026 | S · Sale | −211.00 | $12.78 | $2.70K | 11.7% | 1.80K | 1.59K |
| Total | +352.00 | -$2.70K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
563.00 shares
Shares
−563.00
Strike price
Held after
1.69K
Exercisable
—
2/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock563.00 shares | 2/20/2026 | M · Option Exercise | −563.00 | — | 1.69K |